Endobronchial closure of bronchopleural fistulas with Amplatzer vascular plug

Fruchter, Oren; Bruckheimer, Elchanan; Raviv, Yael; Rosengarten, Dror; Sauté, Milton; Kramer, Mordechai R.

doi:10.1016/j.ejcts.2011.02.080

Cited by 30 publications

(39 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The methods for bronchoscopic deployment of AD and AVP have been described by our group in detail previously [15,16,17], hence only a short description of both techniques is provided.…”

Section: Methodsmentioning

confidence: 99%

“…Early results of the first 10 AD-treated patients and the first 5 AVP-treated patients treated have been described by us previously [16,17]. …”

Section: Introductionmentioning

confidence: 99%

“…This novel treatment is suitable only for patients with large BPF and long tract communicating between the bronchial system and the pleural cavity. For patients with small BPF that are sinus shaped, we described [17] a method of bronchoscopic closure using Amplatzer vascular plugs (AVP) that can be introduced through the working channel of the bronchoscope and deployed under direct vision to seal small BPFs. The major limitation of our previous reports is the relatively short duration of the postprocedural follow-up.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Efficacy of Bronchoscopic Closure of a Bronchopleural Fistula with Amplatzer Devices: Long-Term Follow-Up

et al. 2014

Self Cite

View full text Add to dashboard Cite

Background: The development of a bronchopleural fistula (BPF) is associated with high rates of morbidity and mortality. We have developed a minimally invasive method of bronchoscopic BPF closure using Amplatzer devices (AD) and Amplatzer vascular plugs (AVP), with excellent short-term results. Objectives: The aim of the present report was to explore the long-term outcome of patients treated by Amplatzer occluders and the durability of this novel modality of BPF treatment. Methods: A total of 31 central BPF in 31 patients (mean age 66.8 years, range 19-91) were sealed under moderate sedation bronchoscopically by either AD (n = 19) or AVP (n = 12). The average follow-up period was 17.6 months (range 1-68 months). Results: The main etiology for BPF was surgery (n = 24), pneumonectomy (n = 14) or lobectomy/segmentectomy (n = 10). The underlying disease was either primary (n = 19) or metastatic (n = 2) lung cancer. The immediate success rate was 96% as symptoms related to BPF disappeared in 30 of the 31 patients. Short-term (<30 days) mortality was 13% (4 patients). At follow-up, 14 patients (45%) are still alive. Out of 12 patients with late mortality, in 5 patients (41%) the death was directly related to cancer relapse, and no patient died due to BPF recurrence. Conclusion: Endobronchial closure of BPF using both types of Amplatzer occluders (AD and AVP) is a minimally invasive effective modality of treatment with high safety profile and satisfactory long-term outcome considering the poor prognosis in this particular group of patients.

show abstract

“…The methods for bronchoscopic deployment of AD and AVP have been described by our group in detail previously [15,16,17], hence only a short description of both techniques is provided.…”

Section: Methodsmentioning

confidence: 99%

“…Early results of the first 10 AD-treated patients and the first 5 AVP-treated patients treated have been described by us previously [16,17]. …”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Efficacy of Bronchoscopic Closure of a Bronchopleural Fistula with Amplatzer Devices: Long-Term Follow-Up

et al. 2014

Self Cite

View full text Add to dashboard Cite

show abstract

“…Nine out of ten of the patients in their cohort have been successfully treated with this technique, the only one unsuccessful case was due to a failed anchoring of the device and it's falling into the pleural cavity. The same group published their results with vascular plug device, having five out five successful treatments [17]. Meanwhile there is a raising published evidence in terms of case reports supporting this method in the treatment of central BPF [18][19][20].…”

Section: Bronchoscopic Treatment Of Bronchopleural Fistulamentioning

confidence: 92%

Bronchoscopic management of bronchopleural fistula

Stamenovic¹

2016

Curr Thorac Surg

View full text Add to dashboard Cite

Bronchopleural fistula (BPF) represents a pathological communication between any part of bronchial tree and the pleural space. Mostly it is a rare yet serious complication of different pulmonary conditions like certain infections, trauma, malignancy and/or surgery, going along with significant mortality reported to be as high as 58%. Diagnosis of BPF is mostly done by evaluating these three data: clinical appearance, bronchoscopy and CT scan. The treatment of BPF may initially differ according to the time of appearance as well as clinical presentation. As most BPF goes along with empyema, it is, obviously, necessary to deal with it. This is most commonly achieved with a chest tube. Conservative management of BPF can be achieved using a significant variety of materials and methods with reportedly moderate to excellent results in the treatment of etiologically and sizably different BPF. Methyl-2-cyanoacrylate, fibrin sealant together with spongy calf bone, polidocanol -hydroxypolyethoxidodecane, amplatzer device, silver nitrate, stenting and endobronchial valves have all been employed in bronchoscopic treatment of a BPF. There is no evidence based guideline for its management, either surgically or endoscopically. The treatment of choice is always in the hands of the physician, preferably armed with the current knowledge and capacity of utilizing it.

show abstract

“…Additionally, bronchoscopic technique attempts to spare the fistula, a seemly promising method, also have limitations. The materials included bio-glue, lead shot, polidocanol, silver nitrate, absorbable gelatine sponge, chemical cautery agents, and even valve devices (9,(13)(14)(15). Glue was only eligible for small fistula, and it was easily spilled over into the pleural space or other bronchi.…”

Section: Discussionmentioning

confidence: 99%

Conservative management of empyema-complicated post-lobectomy bronchopleural fistulas: experience of consecutive 13 cases in 9 years

et al. 2016

View full text Add to dashboard Cite

show abstract

Endobronchial closure of bronchopleural fistulas with Amplatzer vascular plug

Abstract: Endobronchial closure using the AVP is a safe and effective method for treatment of small postoperative BPF. The ease of their implantation by bronchoscopy under conscious sedation adds this novel technique to the armatorium of minimally invasive modalities for the treatment of small BPF.

Cited by 30 publications

References 19 publications

Efficacy of Bronchoscopic Closure of a Bronchopleural Fistula with Amplatzer Devices: Long-Term Follow-Up

Efficacy of Bronchoscopic Closure of a Bronchopleural Fistula with Amplatzer Devices: Long-Term Follow-Up

Bronchoscopic management of bronchopleural fistula

Conservative management of empyema-complicated post-lobectomy bronchopleural fistulas: experience of consecutive 13 cases in 9 years

Contact Info

Product

Resources

About